The field of biocatalysis has advanced from harnessing natural enzymes to using directed evolution to obtain new biocatalysts with tailor-made functions 1 . Several tools have recently been developed to expand the natural enzymatic repertoire with abiotic reactions 2, 3 . For example, artificial metalloenzymes, which combine the versatile reaction scope of transition metals with the beneficial catalytic features of enzymes, offer an attractive means to engineer new reactions. Three complementary strategies exist 3 : repurposing natural metalloenzymes for abiotic transformations 2, 4 ; in silico metalloenzyme (re-)design [5] [6] [7] ; and incorporation of abiotic cofactors into proteins [8] [9] [10] [11] . The third strategy offers the opportunity to design a wide variety of artificial metalloenzymes for non-natural reactions. However, many metal cofactors are inhibited by cellular components and therefore require purification of the scaffold protein [12] [13] [14] [15] . This limits the throughput of genetic optimization schemes applied to artificial metalloenzymes and their applicability in vivo to expand natural metabolism. Here we report the compartmentalization and in vivo evolution of an artificial metalloenzyme for olefin metathesis, which represents an archetypal organometallic reaction [16] [17] [18] [19] [20] [21] [22] without equivalent in nature. Building on previous work 6 on an artificial metallohydrolase, we exploit the periplasm of Escherichia coli as a reaction compartment for the 'metathase' because it offers an auspicious environment for artificial metalloenzymes, mainly owing to low concentrations of inhibitors such as glutathione, which has recently been identified as a major inhibitor 15 . This strategy facilitated the assembly of a functional metathase in vivo and its directed evolution with substantially increased throughput compared to conventional approaches that rely on purified protein variants. The evolved metathase compares favourably with commercial catalysts, shows activity for different metathesis substrates and can be further evolved in different directions by adjusting the workflow. Our results represent the systematic implementation and evolution of an artificial metalloenzyme that catalyses an abiotic reaction in vivo, with potential applications in, for example, non-natural metabolism.
The field of biocatalysis has advanced from harnessing natural enzymes to using directed evolution to obtain new biocatalysts with tailor-made functions 1 . Several tools have recently been developed to expand the natural enzymatic repertoire with abiotic reactions 2, 3 . For example, artificial metalloenzymes, which combine the versatile reaction scope of transition metals with the beneficial catalytic features of enzymes, offer an attractive means to engineer new reactions. Three complementary strategies exist 3 : repurposing natural metalloenzymes for abiotic transformations 2, 4 ; in silico metalloenzyme (re-)design [5] [6] [7] ; and incorporation of abiotic cofactors into proteins [8] [9] [10] [11] . The third strategy offers the opportunity to design a wide variety of artificial metalloenzymes for non-natural reactions. However, many metal cofactors are inhibited by cellular components and therefore require purification of the scaffold protein [12] [13] [14] [15] . This limits the throughput of genetic optimization schemes applied to artificial metalloenzymes and their applicability in vivo to expand natural metabolism. Here we report the compartmentalization and in vivo evolution of an artificial metalloenzyme for olefin metathesis, which represents an archetypal organometallic reaction [16] [17] [18] [19] [20] [21] [22] without equivalent in nature. Building on previous work 6 on an artificial metallohydrolase, we exploit the periplasm of Escherichia coli as a reaction compartment for the 'metathase' because it offers an auspicious environment for artificial metalloenzymes, mainly owing to low concentrations of inhibitors such as glutathione, which has recently been identified as a major inhibitor 15 . This strategy facilitated the assembly of a functional metathase in vivo and its directed evolution with substantially increased throughput compared to conventional approaches that rely on purified protein variants. The evolved metathase compares favourably with commercial catalysts, shows activity for different metathesis substrates and can be further evolved in different directions by adjusting the workflow. Our results represent the systematic implementation and evolution of an artificial metalloenzyme that catalyses an abiotic reaction in vivo, with potential applications in, for example, non-natural metabolism.
In the past decade, the biotin-streptavidin technology has proven to be versatile for generating artificial metalloenzymes 12, [23] [24] [25] [26] . This versatility may be traced back to the non-covalent affinity of biotinylated organometallic cofactors for streptavidin (SAV), which ensures their quantitative anchoring in an evolvable protein scaffold. To customize this system for in vivo applications, we designed a strain for periplasmic expression of SAV (SAV peri ) in E. coli. The resulting strain revealed good secretion of functional SAV into the periplasm with no detectable contamination in the cytoplasm (Fig. 1b) .
Staining E. coli cells that harbour SAV peri with Atto-565-biotin yielded a persisting strong fluorescent signal as determined by flow cytometric analysis, whereas the dye-treated strain lacking SAV peri exhibited only low fluorescence (Fig. 1b) . These experiments confirm the biotin-binding activity of SAV peri and suggest that large hydrophobic biotinylated probes (weight-averaged molecular mass of Atto-565-biotin, M w (Atto-565-biotin) = 922 Da) are taken up into the periplasm.
Next, we selected a biotinylated Hoveyda-Grubbs second-generation catalyst (biot-Ru hereafter) to complete the holoenzyme (Fig. 1c) 
27
. Previous experiments using purified SAV revealed that, upon incorporation within SAV, the biot-Ru-SAV complex catalyses the ring-closing metathesis (RCM) of the umbelliferone precursor 1 to afford umbelliferone 2. Despite its poor performance as an RCM substrate in water 27 , we hypothesized that the formation of fluorescent umbelliferone 2, albeit in low yield, would offer an attractive means to monitor and evolve catalytic performance in vivo. Spiking an aqueous reaction mixture with glutathione (GSH; 10 equiv. versus 50 μ M catalyst) led to complete inhibition of biot-Ru-SAV; no umbelliferone 2 was detected. By contrast, upon addition of glutathione disulfide (GSSG) instead of GSH (10 equiv. versus 50 μ M catalyst), the metathesis activity of biot-Ru-SAV was maintained (Extended Data Table 1 ). This suggests that the periplasm may indeed offer a suitable environment to harbour the artificial metathase, because GSH is present in this compartment mainly in its oxidized GSSG form.
To confirm the assembly of the artificial metalloenzyme biot-Ru-SAV within the periplasm, various E. coli strains were treated with the cofactor biot-Ru. Following incubation and washing, the ruthenium content was quantified by inductively coupled plasma optical emission spectrometry (ICP-OES; Fig. 1c ). Although some unspecifically bound ruthenium is present in cells either without SAV at all (SAV − ; approximately 26,000 atoms per cell) or with cytoplasmic SAV (SAV cyto ; approximately 31,000 atoms per cell), a threefold increase in ruthenium concentration was detected in the presence of SAV peri (approximately 80,000 atoms per cell), which suggests that biot-Ru transits through the outer membrane and accumulates in SAV peri . Next, we added the diolefin substrate 1 to E. coli cells bearing biot-Ru-SAV peri . RCM activity yielding umbelliferone 2 was monitored by fluorescence (Fig. 1d) . In contrast to the strain containing only the apoenzyme SAV peri , metathesis activity could be unambiguously detected only for E. coli cells containing the artificial metalloenzyme biot-Ru-SAV peri (Fig. 1d, photograph) . Most importantly, quantification of the fluorescent signal revealed detectable metathesis activity for the strain containing biot-Ru-SAV peri , whereas the free cofactor is largely inhibited in vivo in the absence of the SAV scaffold (Fig. 1d, bar  chart) . These experiments confirm: (i) that there is no E. coli-derived background RCM activity (that is, RCM is bio-orthogonal); (ii) that the bare metathesis cofactor biot-Ru is severely inhibited in E. coli; and (iii) that the periplasm is a propitious compartment to perform RCM with biot-Ru-SAV peri .
To the best of our knowledge, these results represent the first report of the assembly of an artificial metalloenzyme in a whole-cell set-up and its subsequent use as a catalyst in an abiotic transformation in cellulo. By contrast, organometallic-mediated transformations performed so far in a cellular environment typically require multiple equivalents of the precious metal to achieve conversion
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After demonstrating the assembly and activity of the metathase in the periplasm, we sought to evolve biot-Ru-SAV peri towards higher activity. We thus established a streamlined workflow for the growth and expression of different SAV peri mutants in E. coli in a 96-well format (Fig. 2a) . After the induction period, in which SAV peri is synthesized and exported to the periplasm, the cells are harvested by centrifugation, resuspended in a buffer containing the cofactor and incubated for 30 min to allow for the assembly of the artificial metalloenzyme in the periplasm. The buffer containing excess cofactor is then removed by centrifugation, the cells are resuspended in the reaction buffer and RCM is initiated by the addition of substrate 1 and monitored in a microtiter plate reader. This procedure enables thousands of mutants to be screened in only a few days and represents a substantial increase in throughput compared to the conventional workflow that relies on purified mutants.
To improve the performance of the artificial metathase by directed evolution, we designed site saturation mutagenesis libraries of the twenty amino acid residues closest to the modelled position of ruthenium 8 ( Fig. 2b) . Relying on degenerate NNK codons, analysis of 90 clones affords a > 94% probability of screening every possible amino acid residue at one position 29 . Fourteen of the twenty targeted positions revealed a beneficial impact on catalysis in the fluorescence assay and were further selected for iterative saturation mutagenesis 30 . After evaluation of more than 3,000 clones, this directed evolution protocol led to the identification of the quintuple mutant SAV peri (V47A/N49K/T114Q/A119G/K121R) (SAV mut ) in complex with biot-Ru (biot-Ru-SAV mut ), which displayed a cell-specific activity 5.4 ± 1.2 (mean ± s.d.) times higher than that of biot-Ru-SAV peri (Fig. 2c) . Next, the kinetic behaviour of the free cofactor biot-Ru, biot-Ru-SAV and biot-Ru-SAV mut was determined in vitro using purified protein samples and the resulting fluorescence of umbelliferone 2. Even though the limited substrate solubility prevented reaching the maximum reaction velocity V max , all three systems clearly display Michaelis-Menten behaviour (Fig. 3a) . As judged by the kinetic parameters derived from the best fit of the experimental data to a MichaelisMenten model, directed evolution led to an improvement of both V max and the substrate affinity K M . biot-Ru-SAV mut displays a (2.0 ± 0.6)-fold improvement in catalytic efficiency (k cat /K M , where k cat denotes the turnover frequency per cofactor molecule) over the wild-type metathase. To verify the improved catalytic behaviour, we tested the activity of biot-Ru-SAV mut on three independently produced and purified protein batches (Extended Data Fig. 1 ) and varied the ratio between cofactor and SAV binding sites to ensure full complexation (Extended Data Fig. 2 ). Both experiments confirmed the aforementioned trend and the robustness of the proposed system. The X-ray structure of biot-Ru-SAV mut (Protein Data Bank (PDB), 5F2B) reveals two conformations of the cofactor (I and II with 56% and 44% occupancy, respectively; 1 is increased by hydrogenbond swapping with mutation T114Q 1 (red for green dashed line), entropy-raising mutation A119G 1 and bulk-reducing V47A 2 . The superscripts refer to the respective SAV monomers ('1' , blue monomer; '2' , tan monomer). The unresolved alkylidene ligand (magenta) in the crystal structure was modelled.
(Extended Data Fig. 5 ). This loop flexibility can be traced back to three key mutations: T114Q, A119G and V47A. These three mutations have the most pronounced positive effect during evolution (Fig. 2c) , suggesting that increased loop flexibility could be responsible for improved activity.
Despite the versatility of the fluorescence assay, which allowed kinetic activity monitoring in vivo, the substrate surrogate 1 is a notably poor RCM substrate in water 27 (Extended Data Tab. 2). On the basis of past experience with artificial metalloenzymes 24 , we anticipated that the evolved metathase could display broad substrate scope. We thus sought to determine whether the observed positive effect of the mutant on the substrate surrogate 1 would be reflected for typical RCM substrates.
The in vitro catalytic performance for water-soluble substrates 3 and 5 was thus evaluated. For comparative purposes, two commercially available benchmark catalysts were included (second-generation HoveydaGrubbs HGII and AquaMet AQM; Fig. 4a, b and Extended Data Fig. 6 ). For both substrates, the artificial metalloenzymes outperformed the free cofactor biot-Ru as well as the two commercial catalysts. The evolved biot-Ru-SAV mut exhibited greater catalytic performance than biot-Ru-SAV for 2,2-diallyl-1,3-propanediol 3 (Fig. 4a) ; however, for the cationic diallyl-sulfonamide 5, biot-Ru-SAV performed best (Fig. 4b) . Inspection of the structure of biot-Ru-SAV mut (Fig. 3b ) revealed the proximity of the 121R residue to the Ru-alkylidene moiety. In view of the cationic nature of substrate 5, we speculated that electrostatic repulsion of substrate 5 from 121R could reduce the performance of the artificial metalloenzyme because it was evolved for the neutral substrate 1. We therefore re-randomized position 121 by saturation mutagenesis and applied the periplasmic in vivo screening strategy using the cationic substrate 5. The RCM activity to afford the dihydropyrrole 6 was quantified by ultra-performance liquid chromatography mass spectrometry (UPLC-MS) (see Methods; Extended Data Fig. 7 ). This additional round of directed evolution led to the identification of a quintuple mutant SAV peri (47A/49K/114Q/119G/R121L) (SAV mut2 ) with improved activity for the charged substrate 5 both in vitro using purified proteins (Fig. 4b ) and in vivo (Fig. 4c) . The proposed concept for the creation and evolution of an artificial metathase is thus applicable for various substrates and the evolved artificial metalloenzymes exhibit a certain degree of substrate specificity.
This work demonstrates the in vivo applicability of the streptavidinbiotin technology for creating artificial metalloenzymes that catalyse olefin metathesis, a reaction mechanism that is not present among natural enzymes. Although the free cofactor biot-Ru is nearly inactive in cellulo, the corresponding wild-type artificial metalloenzyme biot-Ru-SAV peri endows the cell with metathesis activity. The latter can be improved by directed evolution protocols for different substrates. We anticipate that this work will contribute to the future development and implementation of a set of bio-orthogonal tools to be used in, for example, new non-natural metabolic pathways.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Table 2 ) to add the 21 amino acid OmpA signal peptide (MKKTAIAIAVALAGFATVAQA) to the N terminus of SAV. The PCR product was digested with restriction enzymes NdeI and BamHI, gel purified and ligated into the target vector pET-30b(+ ) (Merck Millipore) pre-treated with the same enzymes. The resulting expression vector, designated pET-30b-SAV peri , carries the gene for the OmpA::SAV fusion protein under the control of a P T7 promoter. To construct a comparable cytoplasmic expression construct, the gene for T7-tagged SAV from pET11b-SAV was PCR-amplified without adding additional amino acids using primers 3 and 2 (Supplementary Table 2 ) and subsequently cloned into pET-30b(+ ) by restriction digest (NdeI and BamHI) and ligation, resulting in plasmid pET-30b-SAV cyto . Construction of the periplasmic expression strain. All strains used in this study are summarized in Supplementary Table 3 . A strain for periplasmic expression was constructed that combines the ease of library generation with the compatibility with the T7-expression system. Therefore, the gene of the T7 RNA polymerase was integrated into the chromosome of E. coli
, Thermo Fisher Scientific) using the λ DE3 Lysogenization Kit (Merck Millipore). The resulting lysogen was designated E. coli TOP10(DE3). Shake flask cultivation and expression of SAV. E. coli TOP10(DE3) containing the respective expression plasmid for SAV (pET-30b-SAV peri or pET-30b-SAV cyto ) was cultivated in a Luria-Bertani (LB) medium (50 ml) 32 supplemented with kanamycin (50 mg l −1 ) in shake flasks (500 ml, 37 °C, 200 r.p.m.). An LB pre-culture was diluted 1:100 in fresh medium and incubation was performed until an optical density at 600 nm (OD 600 ) of about 0.5 was reached. Subsequently, the cultivation temperature was lowered to 20 °C, and the expression of SAV was induced by addition of isopropyl-β -d-thiogalactopyranoside (IPTG, 50 μ M) and cells were harvested by centrifugation (6,000 r.c.f., 2 min) after four hours of induction. The cell pellet was further processed either for fractionation to analyse the cellular protein content or for flow cytometry. Fractioning of cellular protein and analysis. To separate the periplasmic and the cytoplasmic fraction of cellular proteins, the PeriPreps Periplasting Kit (Epicentre Technologies) was used. For in-gel staining of SAV, biotin-4-fluorescein (10 μ M) was added to the respective fractions before sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis. Owing to the binding to the biotinylated fluorescent dye, SAV can be visualized under ultraviolet light in the gel (before staining with Coomassie blue). Owing to its high stability, SAV remains tetrameric and fully functional even under the otherwise denaturing conditions of SDS-PAGE. Flow cytometry. To stain SAV in whole cells of E. coli, the pellet of a shake-flask expression culture was resuspended in phosphate buffer saline (PBS 32 ) to a final OD 600 = 1 before the addition of Atto-565-biotin (2 μ M, Atto-Tec GmbH). Cells were incubated on ice (30 min) and subsequently subjected to three wash cycles by centrifugation (6,000 r.c.f., 2 min) and resuspension of the pellet in PBS. The resulting cell suspensions were analysed on a BD LSR Fortessa SORP (BD Biosciences) using a 561-nm laser for the excitation of Atto-565-biotin and a 610/20BP-600LP filter combination for analysis of the emitted fluorescence signal (peak area). The histograms displayed comprise data of 100,000 ungated events for each sample. Cultivation in 96-well plates. For expression of SAV (and mutants thereof) in the 96-deepwell format, LB medium (500 μ l) supplemented with kanamycin (50 mg l −1 ) was inoculated from a single colony and grown until stationary phase (37 °C, 300 r.p.m., 50-mm shaking amplitude). This pre-culture (aliquot of 30 μ l) was used to inoculate a main culture (1 ml) in a modified ZYM-5052 medium 33 that lacked lactose as auto-induction agent, but contained kanamycin (50 mg l
−1
). Induction was performed by the addition of IPTG ([IPTG] final = 50 μ M) and continued for four hours before harvesting. Subsequently, a fraction of the cultures (100 μ l) was set aside for OD 600 determination and the remaining suspension was subjected either to ICP-OES quantification or to metathesis with whole cells. Metathesis activity in the presence of GSH or GSSG. The activity of the artificial metalloenzyme biot-Ru-SAV was quantified in the reaction buffer (100 mM sodium acetate, pH 4.0, 0.5 M MgCl 2 , 2.5% DMSO) both in the presence and absence of 10 equiv. of glutathione (GSH or GSSG; 500 μ M) relative to the amount of the cofactor biot-Ru (50 μ M). The reaction mixture (total volume of 200 μ l) was incubated shaking (16 h, 37 °C) and, after the reaction, 800 μ l of methanol containing 2-phenylethanol (final concentration of 100 μ M) as an internal standard was added. After centrifugation (5 min, 21,000 r.c.f., 4 °C), 500 μ l of the supernatant were diluted with 500 μ l of de-ionized water and the samples were subjected to UPLC analysis.
UPLC analysis was performed using a Waters H-Class Bio using a BEH C18 1.7 μ M column and a flow rate of 0.6 ml min −1 (eluent A, 0.1% formic acid in water; eluent B, 0.1% formic acid in acetonitrile; gradient at 0 min: 90% A, 10% B; at 0.5 min: 90% A, 10% B; at 2.5 min: 10% A, 90% B; at 3.5 min: 90% A, 10% B; at 4.5 min: 90% A, 10% B). The ultraviolet signal at 210 nm was used for quantification, and concentrations of the metathesis product umbelliferone 2 (retention time of 1.38 min) were determined on the basis of a standard curve with commercially available umbelliferone (Sigma Aldrich). ICP-OES quantification of cellular ruthenium content. To quantify the ruthenium content of cells, cultures from 96-deepwell plates were pelleted by centrifugation (3,220 r.c.f., 12 min, 4 °C) and resuspended in ice-cold Tris/HCl-buffer (1 ml, 50 mM, pH 7.4, 0.9% (w/v) NaCl) containing biot-Ru (10 μ M). After incubation on ice (30 min), the cells were spun down (1,260 r.c.f., 8 min, 4 °C) , the supernatantcontaining excess cofactor was discarded, and the pellet was washed by resuspension in ice-cold Tris/HCl-buffer (1 ml), centrifugation and careful removal of the supernatant. Afterwards, the pellet was resuspended in de-ionized water (500 μ l). Twelve replicates of this suspension were combined and concentrated nitric acid was added (550 μ l, 65%) to fully digest the cellular material (48 h, 110 °C, pressure vials). The resulting clear solutions were diluted to a final volume of 10 ml with de-ionized water (containing 1 p.p.m. yttrium as internal standard) and subjected to ICP-OES quantification.
The obtained p.p.b.-values (1 p.p.b. = 1 μ g l −1 ) for ruthenium were transformed into a molar concentration and the average ruthenium atom count per cell was calculated from the OD 600 of the cultures before decomposition assuming an OD 600 -to-cell-number correlation for E. coli in complex medium of 7.8 × 10 8 ml −1 OD 600
, as described in ref. 34 . Fluorescent metathesis assay with whole cells. The cellular metathesis activity was quantified using a fluorescent assay. For this purpose, cell cultures from 96-deepwell plate cultivations (see above) were pelleted by centrifugation (3,220 r.c.f., 12 min) and resuspended in ice-cold Tris/HCl-buffer (500 μ l, 50 mM, pH 7.4) containing biot-Ru (2.1 μ M). This buffer was supplemented with NaCl (0.9% (w/v)) to adjust to a physiological NaCl concentration. To allow cellular uptake of biot-Ru, the suspensions were incubated on ice for 30 min, spun down (1,260 r.c.f., 8 min) and the supernatant with its excess of cofactor was discarded. The pellets were resuspended in the reaction buffer (160 μ l, 100 mM sodium acetate, pH 4.0, 0.5 M MgCl 2 ) and the reaction was initiated by addition of these cell suspensions (150 μ l) to the substrate solution (50 μ l reaction buffer containing 40 mM precursor 1 and 20% DMSO), leading to a final substrate concentration of 10 mM and 5% DMSO. As the metathesis product umbelliferone 2 is fluorescent, the reaction progress was monitored by fluorescence in a microtiter plate reader (excitation wavelength, 322 ± 4.5 nm; emission wavelength, 440 ± 10 nm; Infinite M1000 PRO, Tecan Group AG) at 37 °C and agitation (6-mm amplitude, orbital). Cell-specific metathesis activity is specified as the slope of the increasing fluorescence signal in the linear range of the reaction normalized by the OD 600 of the respective culture. Site-saturation mutagenesis of SAV and screening. To generate diversity in the scaffold protein SAV, a focused, semi-rational strategy was pursued: the 20 amino acid residues closest to the ruthenium ion (see Supplementary Table 4 ) in a related artificial metalloenzyme structure 8 were selected and individually randomized in SAV peri by site-saturation mutagenesis using NNK codons 30 . Degeneration was introduced by application of the Quikchange Site Directed Mutagenesis Protocol (Stratagene) using degenerate oligos (see Supplementary Table 4 ) and, after transformation, the libraries were checked for diversity by Sanger-sequencing of at least four individual clones before screening. To evaluate the performance of the SAV peri variants, the aforementioned fluorescent metathesis assay was carried out with at least 90 clones from the library in one 96-well plate (three replicates of strains producing 'wild-type' SAV (parent) and three replicates of strains carrying an empty vector control (pET-30b(+ ), lacking the gene for SAV peri ). Evaluating 90 members of an NNK library ensures a > 94% likelihood of screening all 20 amino acid residues in the respective position 29 . To compensate for biological variance, promising clones were isolated and subjected to a replicate assay that was identical to the protocol described above, but using eight independent cultures per clone. After this first screening round, promising residues were ordered according to their potential impact on catalysis and mutations were combined using iterative saturation mutagenesis (ISM) 30 . Enzyme kinetics. To perform kinetic experiments on the artificial metathase, the initially used T7-tagged SAV as well as the quintuple mutant SAV mut that was isolated after ISM were cloned into a cytoplasmic expression vector (see Methods section 'Cloning of SAV expression constructs') and purified on an iminobiotin sepharose column as described elsewhere 35 . The biotin binding capacity was determined using a fluorescent quenching assay 36 . Kinetic measurements were performed in reaction buffer (200 μ l total volume, 100 mM sodium acetate, pH 4.0, 0.5 M MgCl 2 , 11.5% (v/v) DMSO) containing biot-Ru (50 μ M) both in the presence and absence of purified SAV (100 μ M binding sites of either T7-tagged SAV or SAV mut ) as well as the substrate 1 (variable concentrations, 0-5 mM) for fluorescent RCM. The reaction was monitored in a microtiter plate reader as described in Methods section 'Fluorescent metathesis assay with whole cells' . The maximum velocity of the reaction was determined from the fluorescent signal curve by linear regression. To retrieve kinetic parameters, the reaction velocities were plotted over the respective substrate concentrations using the software GraphPad Prism (GraphPad Software, version 6.05) and applying the integrated 'Michaelis-Menten' least-squares fit with no constraints for the maximum velocity V max and substrate affinity K M . Protein crystallization and catalyst soaking. Crystals of SAV and variant SAV mut were obtained at 20 °C within two days by the sitting-drop vapour diffusion technique mixing 1 μ l crystallization buffer (1.5 M ammonium sulfate, 0.1 M sodium acetate, pH 4.0) and 4 μ l protein solution (26 mg ml −1 lyophilized protein in water). The droplet was equilibrated against a reservoir solution of 100 μ l crystallization buffer. Subsequently, single crystals were soaked for two days at 20 °C in a soaking buffer, which was prepared by mixing 1 μ l of a 10 mM stock solution of complex biot-Ru (in 50% aqueous DMSO) and 9 μ l crystallization buffer. After the soaking, crystals were transferred for 30 s into a cryo-protectant solution consisting of 25% (v/v) glycerol in crystallization buffer. Next, crystals were shock-frozen in liquid nitrogen. Additional soaking of the above metathase crystals with substrate surrogate 1 did not lead to fluorescence. We therefore conclude that the multiple catalytic steps (for example, ligand displacement and cross-metathesis) required to ultimately liberate umbelliferone 2 cannot take place within a crystal. Data processing and structure refinement. X-ray diffraction data were collected at the Swiss Light Source beam line X06DA at a wavelength of 1 Å and processed with the software XDS 37 and AIMLESS (CCP4 Suite) 38 . The structure was solved by molecular replacement using the program PHASER (CCP4 Suite) 38 and the structure 2QCB from the PDB as an input model with ligand and water molecules removed. For structure refinement REFMAC5 (CCP4 Suite) 39 and PHENIX.REFINE 40 were used. Ligand manipulation was carried out with the program REEL using the small-molecule crystal structure ABEJUM from the Cambridge Structural Database as an input model 40 . For water picking and electron density and structure visualization, the software COOT 41 was used. Figures were drawn with PyMOL (the PyMOL Molecular Graphics System, version 1.5.0.5, Schrödinger, LLC). Crystallographic details, processing and refinement statistics are given in Supplementary Table 5 . Crystal structure of biot-Ru-SAV mut . There is one SAV mut monomer in the asymmetric unit from which a tetramer can be generated by application of two orthogonal crystallographic two-fold symmetry axes. The 12 N-terminal residues of the T7-tag and 25 residues at the C terminus are not resolved, probably owing to disorder.
Residual electron density in the biotin-binding site and the biotin vestibule as well as two strong anomalous dispersion density peaks in the biotin vestibule (Extended Data Fig. 3 ) suggested modelling of complex biot-Ru in two conformations I and II (56% and 44% occupancy, respectively). This projects the ruthenium atom in either one of the two densities, in close proximity to a crystallographic two-fold symmetry axis (Fig. 3b, Extended Data Figs 3, 4c, d) . Only partial or no electron density was present for the mesityl linker and the terminal mesityl group, probably owing to high flexibility. In conformer I, the lengthy dimesitylimidazolidine (DMI)-Ru head group reaches into the neighbouring cis-related SAV mut monomer. The I conformer is stabilized mostly by hydrophobic interactions between the distal face of the DMI ligand and amino acid side chains within two neighbouring cis-related 7,8-loops (L110 Fig. 4c ). Besides the DMI ligand, two chloride ions could be modelled binding to the ruthenium, but no density was found for the alkylidene, presumably owing to high flexibility and/or low occupancy. The orientation of the chlorides was very similar to that in a small-molecule crystal structure of the Grubbs-Hoyveda secondgeneration catalyst (ABEJUM from the Cambridge Structural Database), placing them nearly in trans position to each other. The ruthenium is largely solventexposed, which could facilitate substrate binding and product release. In Fig. 3b , the alkylidene was modelled binding to the ruthenium (magenta stick model) to highlight its orientation in the biotin vestibule. Conformer II is different from I by a rotation (about 60°) of the DMI-Ru moiety around an axis parallel to the cylinder axis of the SAV mut β -barrel (Fig. 3b, Extended Data Fig. 4d ). This rotation places the hydrophobic distal side of the DMI-ligand in proximity to amino acid side chains within loop-5,6
1 (A86, H87), loop-7,8 1 (S112, T114Q) and loop-4,5 3 (D67, S69, A65) of a neighbouring trans-related SAV monomer. Atom N49K-Nε is located in close proximity to ruthenium (2.4 Å). No electron density was found to model chloride ions and the alkylidene ligand bound to the ruthenium. Because the cofactor is bound in close proximity to a two-fold crystal symmetry axis, formation of a cis-symmetry-related neighbouring cofactor by application of the crystal symmetry operation results in extensive steric clashes between the two cofactors in the orientation I. In contrast, coexistence of cofactor pairs I-I or II-II orientation is sterically accessible (Extended Data Fig. 3a, c, e) . Normalized B factors of residues within cofactor-flanking loop-7,8 are increased by up to about 0.5 when compared to related SAV structures that crystalized in the same space group and in a very similar unit cell (Extended Data Fig. 5b ). This suggests increased loop-7,8 flexibility (Fig. 3b, Extended Data Fig. 4c, d ). This flexibility is likely to be caused by three factors: (i) mutation T114Q cleaves a hydrogen-bond between threonine-Oγ H and T115-carbonyl oxygen (green dashed line in Fig. 3b and Extended Data Fig. 4a, b ) and leads to a new hydrogenbond between T114Q-glutamine-Nε and S112-Oγ H (red dashed line in Fig. 3b and Extended Data Fig. 4c, d) ; (ii) mutation A119G in the loop leads to increased entropy; and (iii) mutation V47A reduces steric hindrance between V47A in loop-3,4 2 and W120 in loop-7,8 1 ( Fig. 3b and Extended Data Fig. 4c, d ). Crystal structure of biot-Ru-SAV. The overall structure of complex biot-Ru-SAV is virtually identical to that of complex biot-Ru-SAV mut (root-mean-square deviation, r.m.s.d. = 0.25 Å). As in the mutant, two strong residual electron density peaks (F o − F c cofactor omit map: 12σ (conformer I) and 11σ (conformer II)) and two anomalous dispersion density peaks (9σ (conformer I) and 5σ (conformer II)) were located within the biotin vestibule of a SAV monomer at the interface between two symmetry-related SAV monomers (Extended Data Fig. 3b, d, f) . The same two cofactor conformations I and II found in mutant SAV mut were modelled in the biotin binding vestibule of SAV with an occupancy of 50% for each conformer I and II (Extended Data Fig. 4a, b) .
The side chain of residue L110 adopts two conformations with 50% occupancy each (Extended Data Fig. 4a, b) . The close proximity of the terminal methyl group in L110 conformation A to the aromatic mesityl ring (distance between L110-Cδ H and mesityl centroid of 4.4 Å) of cofactor conformation I suggests a stabilizing σ -π interactions (Extended Data Fig. 4a, red star) . The L110 side chain conformation B can coexist only with cofactor conformation II (Extended Data Fig. 4b ). This hypothesis is supported by the fact that the same L110 side chain conformation A is found in complex [(Cp* )Ir(Biot-p-L)Cl]-SAV-S112A (PDB, 3PK2), which has an aromatic ring located in the same position as the mesityl linker in structure biot-Ru-SAV, suggesting a similar σ -π interaction. In contrast, the side chain of L110 in apo-SAV (PDB, 2BC3) adopts conformation B. In complex biot-Ru-SAV, a water molecule is bound in proximity to L110 with 50% occupancy (Extended Data Fig. 4b ). Steric clashes with L110 side chain in conformation A and the NHC ligand of biot-Ru conformer I suggest that the water is present only with L110 conformation B and biot-Ru conformer II. Additionally, the side chain of L124 adopts two conformations, each with 50% occupancy. Only conformation L124 A does not undergo steric clashes with a methyl group of the bridging mesityl moiety of cofactor conformer I (Extended Data Fig. 4a, b) . Together, the conformational side chain flexibility of residues L110 and L124 reflects the presence of the two cofactor conformations I and II.
In contrast to artificial metalloenzyme biot-Ru-SAV mut , the normalized B factors of residues within the cofactor-flanking loop-7,8 in complex biot-Ru-SAV do not show increased values when compared to those in related crystal structures (Extended Data Fig. 5b ). Indeed, a hydrogen-bond is formed between T114-Oγ H and T115-carbonyl oxygen in complex biot-Ru-SAV that could rigidify the loop (Extended Data Fig. 4a, b) . In vitro metathesis assay for substrate 3 (2,2-diallyl-1,3-propanediol) . The conversion for the product 4 was quantified by 
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Then, an aqueous solution of benzyltriethylammonium chloride (100 μ l, 10 mM) was added as an internal standard and 700 μ l of methanol was added. The mixture was cleared by centrifugation and 250 μ l of the supernatant was mixed with 750 μ l of water for the final quantification of product 6 by UPLC-MS.
For the kinetic experiment, the reaction mixture was scaled up to a total volume of 1 ml and 50 μ l aliquots of this mixture were collected at different time points and immediately injected into 950 μ l of a quenching solution (0.5 mM potassium cyanoacetate, 0.25 mM benzyltriethyl-ammonium chloride (internal standard) in 50% aqueous methanol). After removal of precipitated protein by centrifugation, the supernatant was analysed by UPLC-MS. Metathesis assay with whole cells and diallyl sulfonamide 5. To quantify the cellular metathesis activity for substrate 5, a protocol analogous to that applied for the umbelliferone precursor 1 was applied. The substrate 5 (final concentration 10 mM) was added to whole cells and the samples were incubated at 37 °C and 300 r.p.m. for 16 h. To quantify the conversion for the non-fluorescent product 6, an extraction was performed: 800 μ l of methanol was added to each sample and an extraction was carried out (one hour with vigorous shaking, 800 r.p.m. at room temperature). The samples were cleared by centrifugation, the supernatant was diluted with water (factor four) and analysed by UPLC-MS using a calibration curve recorded for product 6. Sample size. No statistical methods were used to predetermine sample size. 
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